Search for: "Lisa Nicholson "
Results 41 - 60
of 82
Sorted by Relevance
|
Sort by Date
27 Aug 2021, 12:18 pm
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
21 Nov 2020, 7:04 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
12 Oct 2020, 11:52 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsA recent STAT News report found that Operation Warp Speed—the government’s Manhattan Project-style effort to quickly develop a COVID-19 vaccine—has substantial military involvement. [read post]
9 Apr 2021, 8:03 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
9 Feb 2017, 10:51 am
And Defense One tells us that General John Nicholson testified to Congress that Afghanistan needs “thousands” more troops if it is to turn the tide of the “stalemate” that currently exists in the country. [read post]
18 Feb 2021, 10:24 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn our last post, we introduced some of the clinical evidence supporting the use of therapeutic antibodies against COVID-19—including Regeneron’s casirivimab and imdevimab and Eli Lilly’s bamlanivimab—and analyzed the existing problems in the distribution and administration of those therapies. [read post]
29 Jan 2021, 10:26 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
30 Jul 2020, 3:39 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
2 Oct 2020, 7:10 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn recent weeks, a number of articles have reported great concern around the politicization of the approval process for future COVID-19 vaccines. [read post]
2 Jun 2020, 10:31 pm
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
5 Aug 2020, 11:43 am
By Nicholson Price, Rachel Sachs, Jacob S. [read post]
25 Mar 2021, 1:24 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
5 Nov 2021, 8:20 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
30 Jun 2021, 10:31 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
21 Apr 2020, 2:09 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOur recent posts have highlighted shortages in three COVID-19-related knowledge goods: testing, drugs (such as those needed to put patients on ventilators), and clinical trial information about effective treatments. [read post]
24 Jun 2020, 5:36 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
15 Apr 2020, 8:14 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowIt’s now clear that expansive, population-wide testing is part-and-parcel of every successful COVID-19 containment strategy. [read post]
21 Jan 2022, 8:35 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
8 Jun 2022, 5:23 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
